🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

SNRK & Vascular Endothelial Aging

Recruitingn/aAges 18 Years - anyAllTianjin Medical University
NCT07591337 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Cardiovascular diseases pose a serious threat to public health, and their prevalence is on the rise year by year. Vascular aging is an independent risk factor for cardiovascular diseases, and endothelial cell senescence is an early event in vascular aging. Its occurrence can lead to endothelium-dependent vasodilation dysfunction, reduced vascular permeability, and the release of the senescence-associated secretory phenotype (SASP). These vascular pathological changes further damage the vascular media, leading to vascular remodeling and reduced compliance, accelerating the progression of atherosclerosis, and ultimately resulting in cardiovascular diseases such as coronary heart disease and hypertension. Recent research of the investigators has revealed that SNRK, a new member of the AMPK family of cellular energy sensors, plays a key regulatory role in vascular development. Based on this

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Aged 18-80 years, with the capacity to make decisions independently or represented by an authorized legal guardian; 2. Able to provide complete personal information, medical history, and lifestyle history (e.g., smoking and alcohol consumption history); 3. No history of severe cardiovascular disease, and deemed eligible for inclusion by a physician. Exclusion Criteria: 1. Women who are pregnant or may become pregnant; 2. Patients with a history of neurological disorders, tumors, severe cardiovascular or pulmonary disease, liver failure, kidney failure, or blood disorders; 3. Patients who have undergone carotid stenting, carotid endarterectomy, or other similar procedures, or who have unilateral carotid artery occlusion due to any cause; 4. Patients who have participated in another clinical trial within the past 4 weeks; 5. Individuals deemed unsuitable for this clinical trial by the investigators.
💊

What it tests

  • serum tests and carotid ultrasound test
📍

Where

1 site
Tianjin Medical University General Hospital
Tianjin, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy